Levena Biopharma
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4955 Directors Pl Ste 300, San Diego, Ca...Phone Number
(858) 203-4200Website
www.levenabiopharma.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Levena Biopharma
Levena Biopharma Co., Ltd., established in 2013, is a biotechnology company dedicated to enable novel antibody-drug conjugate (ADC) therapeutic development. The company offers partners site-specific conjugation technology (K-LOCK and C-LOCK) and novel proprietary linker toxin. Levena Biopharma currently operates in its research and manufacturing facilities in Suzhou, Nanjing and San Diego with capabilities from ADC discovery research, process/analytical development to GMP production of linker-toxin and ADC conjugate.Explore more
Levena Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Levena Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Levena Biopharma launches new products
Check out if Levena Biopharma is spiking on competitors!
Funding: Get notified immidiatlly once Levena Biopharma has new funding data
Check if Levena Biopharma has recently received funding, and reach out quickly before it becomes old news!
Click to see if Levena Biopharma had a recent Job posting/layoffs
Levena Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Levena Biopharma recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Levena Biopharma
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Levena Biopharma
Compare insights from companies similar to Levena Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Levena Biopharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Levena Biopharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Levena Biopharma.
Levena Biopharma Tech Stack
A closer look at the technologies used by Levena Biopharma
Levena Biopharma News & Media
Levena Biopharma, A Sorrento Company, Announces Positive Clinical Data for Its Out-Licensed A166 Product Candidate, A Third-Generation Anti-HER2-ADC, In Treating Heavily Pretreated HER2-Positive Breast Cancer Patients
SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that its license and development partner, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (“Kelun”), presented at this year’s Chinese Society of Clinical Oncology (CSCO) Guideline Conference (April 23-24, 2022) Phase 1 data for its anti-HER2-ADC, A166. To generate this site-specific third generation ADC, Kelun partnered with Levena Biopharma, a Sorrento company, which provided the
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Levena Biopharma
Sign Up For FreeTo access detailed company insights
Levena Biopharma Co., Ltd., established in 2013, is a biotechnology company dedicated to enable novel antibody-drug conjugate (ADC) therapeutic development. The company offers partners site-specific conjugation technology (K-LOCK and C-LOCK) and novel proprietary linker toxin. Levena Biopharma currently operates in its research and manufacturing fa... Read More
